Shanghai, China

Zhen Zhan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Medshine Discovery Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhen Zhan. Retrieved from https://idiyas.com/inventor/zhen-zhan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhen Zhan: Innovator in Medicinal Chemistry

Introduction

Zhen Zhan is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic applications. His work focuses on creating innovative solutions for treating various diseases.

Latest Patents

Zhen Zhan holds a patent for "Pyrazole compounds as LSD1 inhibitors and applications thereof." This patent discloses a class of pyrazole compounds and their applications in preparing a medicament for treating related diseases. Specifically, it relates to a compound represented by formula (II) and a pharmaceutically acceptable salt thereof. He has 1 patent to his name.

Career Highlights

Zhen Zhan is currently associated with Medshine Discovery Inc., where he continues to advance his research in medicinal chemistry. His work has the potential to impact the pharmaceutical industry significantly.

Collaborations

Zhen Zhan collaborates with talented professionals in his field, including Lingyun Wu and Lele Zhao. Their combined expertise fosters an environment of innovation and discovery.

Conclusion

Zhen Zhan is a dedicated inventor whose work in developing pyrazole compounds showcases his commitment to advancing medicinal chemistry. His contributions are paving the way for new therapeutic options in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…